It has been proposed by researchers at Medical College of Wisconsin to conduct a large-scale clinical trial to assess the improvement in survival rate in cardiac arrest patients, given CPR and ResQ-Valve.
The study would be funded by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health. The ResQ-Valve Study offers a promise in the emergency management of cardiac arrest and severe traumatic injury, and would be studied under the shelter of the Resuscitation Outcomes Consortium (ROC).
The organization has planed to implement a large-scale trial to evaluate the survival and neurological outcome, in addition to the hospital discharge factor. Dr. Tom P. Aufderheide, professor of emergency medicine at the Medical College of Wisconsin has been elected to be the principal investigator for the study.
A sum of $1.5 million would be sanctioned for the Medical College to cover training costs and improve local infrastructure facilities. If the new treatment strategy were found to be safe and efficient, the silent prayers of numerous cardiac arrest patients would be answered soon.